- Home
- IRON vs ARKO Comparison
IRON vs ARKO Comparison
Compare IRON & ARKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- ARKO
- Stock Information
- Founded
- IRON 2017
- ARKO 1970
- Country
- IRON United States
- ARKO United States
- Employees
- IRON N/A
- ARKO N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- ARKO Oil Refining/Marketing
- Sector
- IRON Health Care
- ARKO Energy
- Exchange
- IRON Nasdaq
- ARKO Nasdaq
- Market Cap
- IRON 1.8B
- ARKO 501.4M
- IPO Year
- IRON N/A
- ARKO N/A
- Fundamental
- Price
- IRON $54.75
- ARKO $4.64
- Analyst Decision
- IRON Strong Buy
- ARKO Buy
- Analyst Count
- IRON 11
- ARKO 4
- Target Price
- IRON $92.64
- ARKO $7.19
- AVG Volume (30 Days)
- IRON 423.3K
- ARKO 635.4K
- Earning Date
- IRON 08-07-2025
- ARKO 08-05-2025
- Dividend Yield
- IRON N/A
- ARKO 2.59%
- EPS Growth
- IRON N/A
- ARKO N/A
- EPS
- IRON N/A
- ARKO 0.03
- Revenue
- IRON N/A
- ARKO $8,488,413,000.00
- Revenue This Year
- IRON N/A
- ARKO N/A
- Revenue Next Year
- IRON N/A
- ARKO N/A
- P/E Ratio
- IRON N/A
- ARKO $178.32
- Revenue Growth
- IRON N/A
- ARKO N/A
- 52 Week Low
- IRON $30.82
- ARKO $3.51
- 52 Week High
- IRON $68.73
- ARKO $7.84
- Technical
- Relative Strength Index (RSI)
- IRON 59.95
- ARKO 54.39
- Support Level
- IRON $51.01
- ARKO $4.18
- Resistance Level
- IRON $55.52
- ARKO $4.66
- Average True Range (ATR)
- IRON 2.43
- ARKO 0.26
- MACD
- IRON -0.02
- ARKO 0.02
- Stochastic Oscillator
- IRON 88.42
- ARKO 74.81
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.